Patents by Inventor Bruce J. Persson

Bruce J. Persson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120022626
    Abstract: Devices, systems and methods for nerve stimulation for OSA therapy.
    Type: Application
    Filed: October 3, 2011
    Publication date: January 26, 2012
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
  • Publication number: 20120022609
    Abstract: Devices, systems and methods for nerve stimulation for OSA therapy.
    Type: Application
    Filed: October 3, 2011
    Publication date: January 26, 2012
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
  • Publication number: 20120010681
    Abstract: Devices, systems and methods for nerve stimulation for OSA therapy.
    Type: Application
    Filed: December 29, 2010
    Publication date: January 12, 2012
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
  • Publication number: 20120010532
    Abstract: Devices, systems and methods for nerve stimulation for OSA therapy.
    Type: Application
    Filed: December 29, 2010
    Publication date: January 12, 2012
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
  • Publication number: 20110202106
    Abstract: Devices, systems and methods for nerve stimulation for OSA therapy.
    Type: Application
    Filed: April 25, 2011
    Publication date: August 18, 2011
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Sidney F. Hauschild, Paula M. Kaplan, Brian D. Kuhnley, Keith E. Jasperson, Wondimeneh Tesfayesus, Christopher K. Thorp
  • Publication number: 20110196445
    Abstract: Devices, systems and methods for nerve stimulation for OSA therapy.
    Type: Application
    Filed: April 26, 2011
    Publication date: August 11, 2011
    Inventors: Stephen L Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
  • Publication number: 20110160794
    Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea.
    Type: Application
    Filed: December 29, 2010
    Publication date: June 30, 2011
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Paula M. Kaplan, Adam K. Hoyhtya, Wondimeneh Tesfayesus, Robert E. Atkinson
  • Publication number: 20110152966
    Abstract: Devices, systems and methods for nerve stimulation for OSA therapy.
    Type: Application
    Filed: December 29, 2010
    Publication date: June 23, 2011
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
  • Patent number: 7949400
    Abstract: Devices, systems and methods are disclosed by which the blood pressure, nervous system activity, and neurohormonal activity may be selectively and controllably reduced by activating baroreceptors. A baroreceptor activation device is positioned near a baroreceptor, preferably a baroreceptor located in the carotid sinus. A control system may be used to modulate the baroreceptor activation device. The control system may utilize an algorithm defining a stimulus regimen which promotes long term efficacy and reduces power requirements/consumption. The baroreceptor activation device may utilize RF-coupled or other electrodes to activate the baroreceptors. The electrodes may be adapted for connection to the carotid arteries at or near the carotid sinus, and may be designed to minimize extraneous tissue stimulation.
    Type: Grant
    Filed: November 10, 2009
    Date of Patent: May 24, 2011
    Assignee: CVRx, Inc.
    Inventors: Robert S. Kieval, Bruce J. Persson, David J. Serdar, Peter T. Keith, Martin A. Rossing
  • Publication number: 20110071591
    Abstract: Devices, systems and methods for nerve stimulation for OSA therapy.
    Type: Application
    Filed: July 14, 2010
    Publication date: March 24, 2011
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
  • Patent number: 7840271
    Abstract: Devices, systems and methods by which the blood pressure, nervous system activity, and neurohormonal activity may be selectively and controllably reduced by activating baroreceptors. A baroreceptor activation device is positioned near a baroreceptor, for example a baroreceptor in the carotid sinus. A control system may be used to modulate the baroreceptor activation device. The control system may utilize an algorithm defining a stimulus regimen which promotes long term efficacy and reduces power requirements/consumption.
    Type: Grant
    Filed: July 20, 2005
    Date of Patent: November 23, 2010
    Assignee: CVRx, Inc.
    Inventors: Robert S. Kieval, Bruce J. Persson, David J. Serdar, Peter T. Keith
  • Patent number: 7809442
    Abstract: Devices and methods of use are provided for treating a person having a hypoglossal nerve and an upper airway. In one embodiment, a method may include providing a nerve cuff electrode including a cylindrical cuff body. The method may further include chronically implanting the nerve cuff electrode on a portion of the hypoglossal nerve. The method may also include delivering a stimulus to the hypoglossal nerve via the nerve cuff electrode to mitigate obstruction of the upper airway.
    Type: Grant
    Filed: October 12, 2007
    Date of Patent: October 5, 2010
    Assignee: Apnex Medical, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
  • Publication number: 20100249874
    Abstract: Devices, systems and methods are described by which the blood pressure, nervous system activity, and neurohormonal activity may be selectively and controllably reduced by activating baroreceptors. A baroreceptor activation device is positioned near a baroreceptor, preferably a baroreceptor located in the carotid sinus. A control system may be used to modulate the baroreceptor activation device. The control system may utilize an algorithm defining a stimulus regimen which promotes long term efficacy and reduces power requirements/consumption. The baroreceptor activation device may utilize electrodes to activate the baroreceptors. The electrodes may be adapted for connection to the carotid arteries at or near the carotid sinus, and may be designed to minimize extraneous tissue stimulation.
    Type: Application
    Filed: May 21, 2010
    Publication date: September 30, 2010
    Inventors: Stephen L. Bolea, Robert S. Kieval, Bruce J. Persson, David J. Serdar, Peter T. Keith, Eric D. Irwin, Martin A. Rossing
  • Patent number: 7801614
    Abstract: Baroreflex activation is achieved by providing suitable control signals to a baroreflex activation device. A method comprises establishing a therapy interval (possibly on the order of minutes to hours, or possibly of indefinite duration), within the therapy interval, establishing a plurality of dose intervals, and generating an electrical output signal. The electrical output signal has a time dependence such that the average electrical power applied to the baroreflex activation device differs between first and second portions of at least some dose intervals. Another method comprises establishing a series of therapy interval portions, during at least some therapy intervals, establishing a plurality of burst intervals (perhaps having durations commensurate with an interval between heartbeats), and generating an electrical output signal.
    Type: Grant
    Filed: October 23, 2006
    Date of Patent: September 21, 2010
    Assignee: CVRx, Inc.
    Inventors: Martin A. Rossing, Robert S. Kieval, David J. Serdar, Bruce J. Persson
  • Publication number: 20100222831
    Abstract: Devices, systems and methods are described by which the blood pressure, nervous system activity, and neurohormonal activity may be selectively and controllably reduced by activating baroreceptors. A baroreceptor activation device is positioned near a baroreceptor, preferably a baroreceptor located in the carotid sinus. A control system may be used to modulate the baroreceptor activation device. The control system may utilize an algorithm defining a stimulus regimen which promotes long term efficacy and reduces power requirements/consumption. The baroreceptor activation device may utilize electrodes to activate the baroreceptors. The electrodes may be adapted for connection to the carotid arteries at or near the carotid sinus, and may be designed to minimize extraneous tissue stimulation.
    Type: Application
    Filed: April 19, 2010
    Publication date: September 2, 2010
    Inventors: Stephen L. Bolea, Robert S. Kieval, Bruce J. Persson, David J. Serdar, Peter T. Keith, Eric D. Irwin, Martin A. Rossing
  • Publication number: 20100179614
    Abstract: Devices, systems and methods are disclosed by which the blood pressure, nervous system activity, and neurohormonal activity may be selectively and controllably reduced by activating baroreceptors. An intravascularly implantable medical device may include a sleeve formed at least in part of an expandable member configured to be movably attachable about at least a portion of an outer surface of an expandable intravascular stent, and one or more electrodes disposed on the sleeve and coupled to a control system and configured to selectively activate baroreceptors within a wall of a vessel when the expandable intravascular stent is implanted within the vessel.
    Type: Application
    Filed: March 8, 2010
    Publication date: July 15, 2010
    Inventors: Robert S. Kieval, Bruce J. Persson, David J. Serdar, Peter T. Keith, Martin A. Rossing
  • Publication number: 20100174347
    Abstract: Devices, systems and methods are disclosed by which the blood pressure, nervous system activity, and neurohormonal activity may be selectively and controllably reduced by activating baroreceptors. A baroreceptor activation device is positioned near a baroreceptor, preferably a baroreceptor located in the carotid sinus. A control system may be used to modulate the baroreceptor activation device. The control system may utilize an algorithm defining a stimulus regimen which promotes long term efficacy and reduces power requirements/consumption. The baroreceptor activation device may utilize RF-coupled or other electrodes to activate the baroreceptors. The electrodes may be adapted for connection to the carotid arteries at or near the carotid sinus, and may be designed to minimize extraneous tissue stimulation.
    Type: Application
    Filed: November 10, 2009
    Publication date: July 8, 2010
    Inventors: Robert S. Kieval, Bruce J. Persson, David J. Serdar, Peter T. Keith, Martin A. Rossing
  • Publication number: 20100174341
    Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea.
    Type: Application
    Filed: December 30, 2009
    Publication date: July 8, 2010
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Paula M. Kaplan, Adam K. Hoyhtya, Wondimeneh Tesfayesus, Robert E. Atkinson
  • Patent number: 7623926
    Abstract: Baroreflex activation is achieved by providing suitable control signals to a baroreflex activation device. A method comprises establishing a therapy interval (possibly on the order of minutes to hours, or possibly of indefinite duration), within the therapy interval, establishing a plurality of dose intervals, and generating an electrical output signal. The electrical output signal has a time dependence such that the average electrical power applied to the baroreflex activation device differs between first and second portions of at least some dose intervals. Another method comprises establishing a series of therapy interval portions, during at least some therapy intervals, establishing a plurality of burst intervals (perhaps having durations commensurate with an interval between heartbeats), and generating an electrical output signal.
    Type: Grant
    Filed: April 5, 2004
    Date of Patent: November 24, 2009
    Assignee: CVRx, Inc.
    Inventors: Martin A. Rossing, Robert S. Kieval, David J. Serdar, Bruce J. Persson
  • Patent number: 7616997
    Abstract: Devices, systems and methods are disclosed by which the blood pressure, nervous system activity, and neurohormonal activity may be selectively and controllably reduced by activating baroreceptors. A baroreceptor activation device is positioned near a baroreceptor, preferably a baroreceptor located in the carotid sinus. A control system may be used to modulate the baroreceptor activation device. The control system may utilize an algorithm defining a stimulus regimen which promotes long term efficacy and reduces power requirements/consumption. The baroreceptor activation device may utilize RF-coupled or other electrodes to activate the baroreceptors. The electrodes may be adapted for connection to the carotid arteries at or near the carotid sinus, and may be designed to minimize extraneous tissue stimulation.
    Type: Grant
    Filed: March 27, 2003
    Date of Patent: November 10, 2009
    Inventors: Robert S. Kieval, Bruce J. Persson, David J. Serdar, Peter T. Keith, Martin A. Rossing